Recent News

• 06.11.2025 - Iterum Therapeutics Announces Partnership for Commercialization Services
• 06.11.2025 - Iterum Therapeutics Announces Partnership for Commercialization Services
• 05.19.2025 - Iterum Therapeutics Announces Extension of Term of Promissory Note
• 05.19.2025 - Iterum Therapeutics Announces Extension of Term of Promissory Note
• 05.13.2025 - Iterum Therapeutics Reports First Quarter 2025 Financial Results
• 05.06.2025 - Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025
• 04.30.2025 - Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
• 04.30.2025 - Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
• 04.29.2025 - Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
• 04.29.2025 - Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares

Recent Filings

• 06.11.2025 - 8-K Current report
• 05.19.2025 - 8-K Current report
• 05.19.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 8-K Current report
• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 04.30.2025 - 8-K Current report
• 04.30.2025 - EX-99.1 EX-99.1